C3435T polymorphism of the ABCB1/MDR1 gene encoding P-glycoprotein in patients with inflammatory bowel disease in a Polish population

Pharmacological Reports

Volumn 64, Issue 2, 2012, Pages 343-350

  Dudarewicz, Michał ^a   Barańska, Małgorzata ^a   Rychlik Sych, Mariola ^a   Trzciński, Radzisław ^a   Dziki, Adam ^a   Skreţkowicz, Jadwiga ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

ABCB1 MDR1 gene; Genetic polymorphisms; Inflammatory bowel disease; P glycoprotein

Indexed keywords

CYSTEINE; MULTIDRUG RESISTANCE PROTEIN 1; THREONINE;

ABCB1 GENE; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; MUTATOR GENE; POLAND; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ULCERATIVE COLITIS;

EID: 84862214814     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70774-0     Document Type: Article

References (31)

1. Ameyaw MM, Regateiro F, Li T, Liu X, Tariq M, Mobarek A, Thornton N et al.: MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics, 2001, 11, 217-221. (Pubitemid 32319871)
2. Ardizzone S, Maconi G, Bianchi V, Russo A, Colombo E, Cassinotti A, Penati C et al.: Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease. Inflamm Bowel Dis, 2007, 13, 516-523. (Pubitemid 46799634)
3. Całka K, Balcerczak E, Sałagacka A, Mirowski M: Multidrug resistant proteins in multiple myeloma (Polish). Acta Haematol Pol, 2008, 39, 417-428.
4. Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E et al.: Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther, 2001, 69, 169-174. (Pubitemid 32225417)
5. Cho JH: The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol, 2008, 8, 458-466.
6. DrożdzikM, Białecka M, Myoeliwiec K, Honczarenko K, Stankiewicz J, Sych Z: Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics, 2003, 13, 259-263. (Pubitemid 36583992)
7. Eder P, Stawczyk K, Krela-Kaźmierczak I, Linke K: Chosen markers of inflammatory bowel diseases (Polish). Gastroenterol Pol 2007, 14, 429-431.
8. Farnood A, Naderi N, Moghaddam SJM, Noorinayer B, Firouzi F, Aghazadeh R, Daryani NE, Zali MR: The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis. Int J Colorectal Dis, 2007, 22, 999-1003. (Pubitemid 47500239)
9. Fiedler T, Büning C, Reuter W, Pitre G, Gentz E, Schmidt HH, Büttner J et al.: Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease. Eur J Clin Pharmacol, 2007, 63, 917-925. (Pubitemid 47387906)
10. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H et al.: Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet, 2001, 357, 1925-1928. (Pubitemid 32568333)
11. Ho G-T, Moodie FM, Satsangi J: Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? Gut, 2003, 52, 759-766. (Pubitemid 36528884)
12. Ho G-T, Nimmo ER, Tenesa A, Fennell J, Drummond H, Mowat C, Arnott ID, Satsangi J: Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology, 2005, 128, 288-296. (Pubitemid 40431082)
13. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmöller J, Johne A, Cascorbi I et al.: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with Pglycoprotein expression and activity in vivo. Proc Natl Acad Sci USA, 2000, 97, 3473-3478. (Pubitemid 30183327)
14. Jamroziak K, Balcerczak E, Młynarski W, Mirowski M, Robak T: Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population. Pol J Pharmacol, 2002, 54, 495-500. (Pubitemid 35214975)
15. Kerb R: Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett, 2006, 234, 4-33.
16. Kurzawski M, Droździk M, Suchy J, Kurzawski G, Białecka M, GórnikW, Lubiński J: Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol, 2005, 61, 389-394. (Pubitemid 41569314)
17. Maresca M, Fantini J: Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. Toxicon, 2010, 56, 282-294.
18. Molodecky NA, Kaplan GG: Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol, 2010, 6, 339-346.
19. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H et al.: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 2001, 411, 603-606. (Pubitemid 32531409)
20. Onnie CM, Fisher SA, Pattni R, Sanderson J, Forbes A, Lewis CM, Mathew CG: Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study. Inflamm Bowel Dis, 2006, 12, 263-271.
21. Oostenbrug LE, van Dullemen HM, te Meerman GJ, Jansen PL. IBD and genetics: new developments. Scand J Gastroenterol Suppl. 2003, 239, 63-68. (Pubitemid 38112917)
22. Pańczyk M, Sałagacka A, Mirowski M: MDR1 (ABCB1) gene encoding glycoprotein P (P-gp), a member of ABC transporter superfamily: consequences for therapy and progression of neoplastic diseases (Polish). Postȩpy Biochem, 2007, 53, 361-373.
23. Petryszyn P, Semianów-Wejchert J, Annabhani A, Paradowski L: Quality of life, education, occupational and social status of patients with inflammatory bowel disease - literature review (Polish). Gastroenterol Pol, 2008, 15, 421-424.
24. Pithadia AB, Jain S: Treatment of inflammatory bowel disease (IBD). Pharmacol Rep, 2011, 63, 629-642.
25. Potočnik U, Ferkolj I, Glavač D, Dean M: Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun, 2004, 5, 530-539. (Pubitemid 39529969)
26. Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, Stange E et al.: Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology, 2003, 124, 26-33. (Pubitemid 36055335)
27. Swidsinski A, Loening-Baucke V, Herber A: Mucosal flora in Crohn's disease and ulcerative colitis - an overview. J Physiol Pharmacol, 2009, 60, Suppl 6, 61-71.
28. Szeliga J, Sońdka Z, Jackowski M, Jarkiewicz-Tretyn J, Tretyn A: The outline of immunopathogenesis of Crohn's disease with special consideration of NOD2/CARD15 gene polymorphism (Polish). Gastroenterol Pol, 2007, 14, 129-133. (Pubitemid 46662993)
29. Urcelay E, Mendoza JL, Martín MC, Mas A, Martínez A, Taxonera C, Fernandez-Arquero M et al.: MDR1 gene: susceptibility in Spanish Crohn's disease and ulcerative colitis patients. Inflamm Bowel Dis, 2006, 12, 33-37. (Pubitemid 43032449)
30. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM; Genome Scan Meta-Analysis Group of the IBD International Genetics Consortium: Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet, 2004, 13, 763-770. (Pubitemid 38455963)
31. Yacyshyn B, Maksymowych W, Bowen-Yacyshyn MB: Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis. Hum Immunol, 1999, 60, 677-687. (Pubitemid 29380038)